Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Circulation
    September 2024
  1. JIANG X, Mahfoud F, Li W, Dong H, et al
    Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069215.
    >> Share

    August 2024
  2. HONG J, Medzikovic L, Sun W, Wong B, et al
    Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.124.069864.
    >> Share

  3. XU X, Divakaran S, Weber BN, Hainer J, et al
    Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.
    Circulation. 2024 Aug 21. doi: 10.1161/CIRCULATIONAHA.123.067083.
    >> Share

  4. ZHANG Z, Liu K, Chen X
    Letter by Zhang et al Regarding Article, "Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program".
    Circulation. 2024;150:e181-e182.
    >> Share

    July 2024
  5. LIU B, Yi D, Xia X, Ramirez K, et al
    General Capillary Endothelial Cells Undergo Reprogramming Into Arterial Endothelial Cells in Pulmonary Hypertension Through HIF-2alpha/Notch4 Pathway.
    Circulation. 2024;150:414-417.
    >> Share

  6. COOPER LA, Marsteller JA, Carson KA, Dietz KB, et al
    Equitable Care for Hypertension: Blood Pressure and Patient-Reported Outcomes of the RICH LIFE Cluster Randomized Trial.
    Circulation. 2024;150:230-242.
    >> Share

    June 2024
  7. HOEPER MM, Oerke B, Wissmuller M, Leuchte H, et al
    Tadalafil for Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction: A Randomized Controlled Phase 3 Study.
    Circulation. 2024 Jun 28. doi: 10.1161/CIRCULATIONAHA.124.069340.
    >> Share

  8. ZHANG Q, Yaoita N, Tabuchi A, Liu S, et al
    Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
    Circulation. 2024 Jun 14. doi: 10.1161/CIRCULATIONAHA.124.068726.
    >> Share


  9. Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1412.
    >> Share

    May 2024
  10. SALAHUDDIN A, Harris IS, Sabanayagam A
    Double Whammy Complicating Management of Pulmonary Hypertension.
    Circulation. 2024;149:1770-1774.
    >> Share

  11. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    >> Share

  12. HOEPER MM, Ewert R, Jansa P, Sirenko Y, et al
    Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.123.068107.
    >> Share

  13. RUBIN LJ
    Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
    Circulation. 2024;149:1565-1567.
    >> Share

  14. HARING B, Andrews CA, Hovey K, Shadyab AH, et al
    Systolic Blood Pressure and Survival to Very Old Age: Results From the Women's Health Initiative.
    Circulation. 2024;149:1568-1577.
    >> Share

  15. TANG H, Gupta A, Morrisroe SA, Bao C, et al
    Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
    Circulation. 2024 May 2. doi: 10.1161/CIRCULATIONAHA.123.065304.
    >> Share

    April 2024
  16. BORDAN Z, Batori R, Haigh S, Li X, et al
    PDZ-Binding Kinase, a Novel Regulator of Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2024 Apr 29. doi: 10.1161/CIRCULATIONAHA.123.067095.
    >> Share

  17. RAO RJ, Chan SY
    Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
    Circulation. 2024;149:1372-1374.
    >> Share

  18. GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
    Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
    >> Share

  19. KANDZARI DE, Weber MA, Pathak A, Zidar JP, et al
    Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results from the TARGET BP I Randomized Clinical Trial.
    Circulation. 2024 Apr 8. doi: 10.1161/CIRCULATIONAHA.124.069291.
    >> Share

  20. SHEN H, Gao Y, Ge D, Tan M, et al
    BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension.
    Circulation. 2024 Apr 1. doi: 10.1161/CIRCULATIONAHA.123.066430.
    >> Share

    March 2024
  21. PETER JG, Ntusi NAB, Ntsekhe M
    Are Recommendations That Favor Other Agents Over Angiotensin-Converting Enzyme Inhibitors in Africans With Hypertension Justified?
    Circulation. 2024;149:804-806.
    >> Share

  22. AGGARWAL V, Giri J, Visovatti SH, Mahmud E, et al
    Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 7. doi: 10.1161/CIR.0000000000001197.
    >> Share

    February 2024
  23. REDING KW, Jordan JH
    Multimodal Imaging Evidence for Optimized Blood Pressure Control Following Hypertensive Pregnancy: Mechanistic Insights Into Beneficial Cardiac Remodeling From the POP-HT Trial.
    Circulation. 2024;149:542-544.
    >> Share

  24. PITT B, Williams GH
    Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators?
    Circulation. 2024;149:414-416.
    >> Share

  25. LUO Y, Qi X, Zhang Z, Zhang J, et al
    Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension.
    Circulation. 2024 Feb 5. doi: 10.1161/CIRCULATIONAHA.123.067579.
    >> Share

    January 2024
  26. BIAN JS, Chen J, Zhang J, Tan J, et al
    ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
    Circulation. 2024 Jan 12. doi: 10.1161/CIRCULATIONAHA.123.067005.
    >> Share

    December 2023
  27. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    >> Share

  28. REAY WR, Clarke E, Eslick S, Riveros C, et al
    Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension.
    Circulation. 2023 Dec 22. doi: 10.1161/CIRCULATIONAHA.123.065394.
    >> Share

  29. RASMUSSEN SB, Jeppesen KK, Kjaergaard J, Hassager C, et al
    Blood Pressure and Oxygen Targets on Kidney Injury After Cardiac Arrest.
    Circulation. 2023;148:1860-1869.
    >> Share

    November 2023
  30. HUNDEMER GL, Agharazii M, Madore F, Vaidya A, et al
    Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066389.
    >> Share

  31. WALTERS R, Vasilaki E, Wilkins MR, Zhao L, et al
    Response by Walters et al to Letter Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1825-1826.
    >> Share

  32. LI G, Chen H, Ren C
    Letter by Li et al Regarding Article, "SOX17 Enhancer Variants Disrupt Transcription Factor Binding and Enhancer Inactivity Drives Pulmonary Hypertension".
    Circulation. 2023;148:1823-1824.
    >> Share

  33. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    >> Share

  34. KITT J, Krasner S, Barr L, Frost A, et al
    Cardiac Remodeling After Hypertensive Pregnancy Following Physician-Optimized Blood Pressure Self-Management: The POP-HT Randomized Clinical Trial Imaging Sub-study.
    Circulation. 2023 Nov 11. doi: 10.1161/CIRCULATIONAHA.123.067597.
    >> Share

    October 2023
  35. AZIZI M, Sharp ASP, Fisher NDL, Weber MA, et al
    Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months Following Medication Escalation: The RADIANCE Clinical Trial Program.
    Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.066941.
    >> Share

  36. OSTROMINSKI JW, Vaduganathan M, Selvaraj S, Claggett BL, et al
    Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065254.
    >> Share

    September 2023
  37. KUEHN BM
    Experimental Drug, Combination Pill Show Promise for Treating Pulmonary Hypertension.
    Circulation. 2023;148:852-854.
    >> Share

    August 2023
  38. WANG Z, Du X, Hua C, Li W, et al
    The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial.
    Circulation. 2023;148:565-574.
    >> Share

    July 2023
  39. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
    Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET
    Circulation. 2023;148:375-377.
    >> Share


  40. Correction to: Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2023;148:e2.
    >> Share

    May 2023
  41. GARDNER CD, Vadiveloo MK, Petersen KS, Anderson CAM, et al
    Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:1715-1730.
    >> Share

  42. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
    Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717.
    >> Share


  43. Correction to: Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.
    Circulation. 2023;147:e718.
    >> Share

    April 2023
  44. GUIGNABERT C, Savale L, Boucly A, Thuillet R, et al
    Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
    Circulation. 2023 Apr 25. doi: 10.1161/CIRCULATIONAHA.122.061501.
    >> Share

  45. WALTERS R, Vasilaki E, Aman J, Chen CN, et al
    SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.
    Circulation. 2023 Apr 17. doi: 10.1161/CIRCULATIONAHA.122.061940.
    >> Share

  46. MITCHELL BD, Whitlatch HB
    Decoding Hypertension Through Primary Aldosteronism.
    Circulation. 2023;147:1110-1111.
    >> Share

    March 2023
  47. PITT B, Vaidya A
    Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension.
    Circulation. 2023;147:991-992.
    >> Share

  48. HINKLE SN, Schisterman EF, Liu D, Pollack AZ, et al
    Pregnancy Complications and Long-Term Mortality in a Diverse Cohort.
    Circulation. 2023;147:1014-1025.
    >> Share

  49. RAJAGOPAL S, Ruetzler K, Ghadimi K, Horn EM, et al
    Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 16. doi: 10.1161/CIR.0000000000001136.
    >> Share

    February 2023
  50. NAITO T, Inoue K, Sonehara K, Baba R, et al
    Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Study.
    Circulation. 2023 Feb 21. doi: 10.1161/CIRCULATIONAHA.122.062349.
    >> Share

  51. CHIN KM, Santiago-Munoz P
    Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?
    Circulation. 2023;147:562-564.
    >> Share

  52. BADROV MB, Yoo JK, Hissen SL, D'Souza AW, et al
    Muscle Sympathetic Action Potential Firing Patterns During Normotensive and Hypertensive Pregnancy: A Longitudinal Assessment.
    Circulation. 2023;147:611-613.
    >> Share

  53. ZHANG Q, Zhu F, Shi G, Hu C, et al
    Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
    Circulation. 2023;147:549-561.
    >> Share

  54. GRASHOW R, Tan CO, Izzy S, Taylor HA Jr, et al
    Association Between Concussion Burden During Professional American-style Football and Post-career Hypertension.
    Circulation. 2023 Feb 7. doi: 10.1161/CIRCULATIONAHA.122.063767.
    >> Share

  55. KUEHN BM
    No Benefit Seen for Nighttime Dosing Over Morning Dosing for Antihypertensive Medications.
    Circulation. 2023;147:512-514.
    >> Share

    January 2023
  56. BERRY JD, Chen H, Nambi V, Ambrosius WT, et al
    Effect of Intensive Blood Pressure Control on Troponin and Natriuretic Peptide Levels: Findings From SPRINT.
    Circulation. 2023;147:310-323.
    >> Share

    December 2022
  57. OBEL LM, Lindholt JS, Lasota AN, Jensen HK, et al
    Clinical Characteristics, Incidences, and Mortality Rates for Type A and B Aortic Dissections: A Nationwide Danish Population-Based Cohort Study From 1996 to 2016.
    Circulation. 2022;146:1903-1917.
    >> Share

  58. BORN E, Lipskaia L, Breau M, Houssaini A, et al
    Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Circulation. 2022 Dec 14. doi: 10.1161/CIRCULATIONAHA.122.058794.
    >> Share

    November 2022
  59. AGARWAL R
    Hydrochlorothiazide Versus Chlorthalidone: What Is the Difference?
    Circulation. 2022;146:1641-1643.
    >> Share

  60. ZHOU W, Liu K, Zeng L, He J, et al
    Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
    Circulation. 2022 Nov 17. doi: 10.1161/CIRCULATIONAHA.122.061900.
    >> Share


  61. Correction to: Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
    Circulation. 2022;146:e280.
    >> Share

    October 2022
  62. ERCU M, Mucke MB, Pallien T, Marko L, et al
    Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
    Circulation. 2022 Oct 19:101161CIRCULATIONAHA122060210.
    >> Share

    September 2022
  63. BAI C, Su M, Zhang Y, Lin Y, et al
    Oviductal Glycoprotein 1 Promotes Hypertension by Inducing Vascular Remodeling Through an Interaction With MYH9.
    Circulation. 2022 Sep 29:101161CIRCULATIONAHA121057178.
    >> Share


  64. Correction to: Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2022;146:e168.
    >> Share

  65. VIDAL-PETIOT E
    Thresholds for Hypertension Definition, Treatment Initiation, and Treatment Targets: Recent Guidelines at a Glance.
    Circulation. 2022;146:805-807.
    >> Share

  66. GOTO S, Solanki D, John JE, Yagi R, et al
    Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection.
    Circulation. 2022;146:755-769.
    >> Share

    August 2022
  67. AGARWAL R, Sinha AD, Tu W
    Chlorthalidone for Resistant Hypertension in Advanced Chronic Kidney Disease.
    Circulation. 2022;146:718-720.
    >> Share

  68. CAO N, Lan C, Chen C, Xu Z, et al
    Prenatal Lipopolysaccharides Exposure Induces Transgenerational Inheritance of Hypertension.
    Circulation. 2022 Aug 25:CIRCULATIONAHA122059891.
    >> Share

  69. BRUSCA SB, Elinoff JM, Zou Y, Jang MK, et al
    Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
    Circulation. 2022 Aug 25:101161CIRCULATIONAHA121056719.
    >> Share

  70. YAKU A, Inagaki T, Asano R, Okazawa M, et al
    Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Circulation. 2022 Aug 23:101161CIRCULATIONAHA122059435.
    >> Share

  71. RUFFENACH G, Medzikovic L, Aryan L, Li M, et al
    HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
    Circulation. 2022 Aug 22:101161CIRCULATIONAHA122059591.
    >> Share

  72. TOUYZ RM
    TRPV4 Channel-Regulated Microdomains Define a New Paradigm in Hypertension.
    Circulation. 2022;146:565-568.
    >> Share

  73. CHEN YL, Daneva Z, Kuppusamy M, Ottolini M, et al
    Novel Smooth Muscle Ca(2+)-Signaling Nanodomains in Blood Pressure Regulation.
    Circulation. 2022;146:548-564.
    >> Share

  74. WHELTON PK, Carey RM, Mancia G, Kreutz R, et al
    Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations.
    Circulation. 2022 Aug 11:101161CIRCULATIONAHA121054602.
    >> Share

  75. WELLS CE, Cunningham FG
    Treatment of Chronic Hypertension in Pregnancy: Is It Time for a Change?
    Circulation. 2022;146:433-434.
    >> Share

    July 2022
  76. WANG Y, Feng L, Zeng G, Zhu H, et al
    Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial.
    Circulation. 2022;146:303-315.
    >> Share

  77. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    >> Share

  78. TREMBLAY E, Gosselin C, Mai V, Lajoie AC, et al
    Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2022 Jul 8:101161CIRCULATIONAHA121058635.
    >> Share

    May 2022
  79. BROOK RD, Scirica BM, Levy PD
    "The Doctor Is Out": New Tactics and Soldiers for Our Losing Battle Against Hypertension.
    Circulation. 2022;145:1629-1631.
    >> Share

    March 2022
  80. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    >> Share

  81. STEWART RH, Cox CS Jr, Allen SJ, Laine GA, et al
    Myocardial Edema Provides a Link Between Pulmonary Arterial Hypertension and Pericardial Effusion.
    Circulation. 2022;145:793-795.
    >> Share

  82. KANDZARI DE, Mahfoud F, Weber MA, Townsend R, et al
    Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium.
    Circulation. 2022;145:847-863.
    >> Share

  83. LECHUGA-VIECO AV, Latorre-Pellicer A, Calvo E, Torroja C, et al
    Heteroplasmy of Wild Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
    Circulation. 2022 Mar 3. doi: 10.1161/CIRCULATIONAHA.121.056286.
    >> Share

  84. NIENABER CA, Yuan X
    Taming Hypertension to Prevent Aortic Dissection: Universal Recognition of a "New Normal" Blood Pressure?
    Circulation. 2022;145:645-647.
    >> Share

    February 2022
  85. VEITH C, Varturk-Ozcan I, Wujak M, Hadzic S, et al
    Secreted Protein Acidic and Rich in Cysteine, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
    Circulation. 2022 Feb 17. doi: 10.1161/CIRCULATIONAHA.121.057001.
    >> Share

  86. HONIGBERG MC, Zekavat SM, Raghu VK, Natarajan P, et al
    Microvascular Outcomes in Women With a History of Hypertension in Pregnancy.
    Circulation. 2022;145:552-554.
    >> Share

  87. MACINTYRE IM, Turtle EJ, Farrah TE, Graham C, et al
    Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
    Circulation. 2022;145:416-423.
    >> Share

  88. SMITH SM, Cooper-DeHoff RM
    Acetaminophen-Induced Hypertension: Where Have All the "Safe" Analgesics Gone?
    Circulation. 2022;145:424-426.
    >> Share

    January 2022
  89. LAFFIN LJ, Kaufman HW, Chen Z, Niles JK, et al
    Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic.
    Circulation. 2022;145:235-237.
    >> Share

    November 2021

  90. Correction to: National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021;144:e333.
    >> Share

  91. NAEIJE R
    Letter by Naeije Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e328-e329.
    >> Share

  92. HOWDEN EJ, Ruiz-Carmona S, La Gerche A, Delcroix M, et al
    Response by Howden et al to Letter Regarding Article, "Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Circulation. 2021;144:e330-e331.
    >> Share

  93. HIBINO M, Otaki Y, Kobeissi E, Pan H, et al
    Blood Pressure, Hypertension and The Risk of Aortic Dissection Incidence and Mortality: results from the Japan-Specific Health Checkups Study, the UK Biobank Study and a Meta-analysis of Cohort Studies.
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.056546.
    >> Share

  94. LU Y, Wang Y, Spatz ES, Onuma O, et al
    National Trends and Disparities in Hospitalization for Acute Hypertension Among Medicare Beneficiaries (1999-2019).
    Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057056.
    >> Share

    October 2021
  95. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    >> Share

  96. WEI J, Fang D
    Letter by Wei and Fang Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e236.
    >> Share

  97. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Response by Filippini et al to Letter Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies".
    Circulation. 2021;144:e237.
    >> Share

    September 2021
  98. BLUMENTHAL JA, Hinderliter AL, Smith PJ, Mabe S, et al
    Effects of Lifestyle Modification on Patients With Resistant Hypertension: Results of the TRIUMPH Randomized Clinical Trial.
    Circulation. 2021 Sep 27. doi: 10.1161/CIRCULATIONAHA.121.055329.
    >> Share

  99. LEO F, Suvorava T, Heuser SK, Li J, et al
    Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure.
    Circulation. 2021;144:870-889.
    >> Share

    August 2021
  100. LEOPOLD JA
    Nanoparticle-Facilitated Gene Delivery in Congenital Pulmonary Vascular Disease: Roadmap for Other Forms of Pulmonary Hypertension.
    Circulation. 2021;144:556-558.
    >> Share

    July 2021
  101. QI H, Liu H, Pullamsetti SS, Gunther S, et al
    Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells is Required to Prevent Pulmonary Hypertension and COPD.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.051680.
    >> Share

    June 2021
  102. SATOH T, Wang L, Espinosa-Diez C, Wang B, et al
    Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Down Regulation of sGC and Contributes to Exercise-Induced Pulmonary Hypertension in HFpEF.
    Circulation. 2021 Jun 23. doi: 10.1161/CIRCULATIONAHA.121.053889.
    >> Share

  103. RAYNER BL, Spence JD
    Physiological Treatment of Hypertension in Black Patients: Time for Action.
    Circulation. 2021;143:2367-2369.
    >> Share

  104. KAZI DS, Wei PC, Penko J, Bellows BK, et al
    Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value.
    Circulation. 2021;143:2406-2408.
    >> Share

  105. JOSEPH JJ, Pohlman NK, Zhao S, Kline D, et al
    Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.
    Circulation. 2021;143:2355-2366.
    >> Share

  106. SUN F, Wang G, Pradhan A, Xu K, et al
    Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
    Circulation. 2021 Jun 11. doi: 10.1161/CIRCULATIONAHA.121.053980.
    >> Share

  107. BISSERIER M, Mathiyalagan P, Zhang S, Elmastour F, et al
    Regulation of The Methylation and Expression Levels of the BMPR2 Gene by SIN3a As A Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Circulation. 2021 Jun 3. doi: 10.1161/CIRCULATIONAHA.120.047978.
    >> Share

    May 2021
  108. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    >> Share

  109. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    >> Share

  110. BROOK RD, Levy PD, Jamerson KA
    Mission "UnACCOMPLISHed": Optimal Antihypertensive Therapy.
    Circulation. 2021;143:1932-1934.
    >> Share

  111. KARIO K, Ferdinand KC, Vongpatanasin W
    Are SGLT2 Inhibitors New Hypertension Drugs?
    Circulation. 2021;143:1750-1753.
    >> Share

    April 2021
  112. KANEKO H, Yano Y, Itoh H, Morita K, et al
    Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
    Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
    >> Share

  113. FILIPPINI T, Malavolti M, Whelton PK, Naska A, et al
    Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies.
    Circulation. 2021;143:1542-1567.
    >> Share

  114. BRYANT KB, Moran AE, Kazi DS, Zhang Y, et al
    Cost-effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.051683.
    >> Share

  115. HOWDEN EJ, Ruiz-Carmona S, Claeys M, de Bosscher R, et al
    Oxygen Pathway Limitations in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Circulation. 2021 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.052899.
    >> Share

    November 2020
  116. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
    Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016